Title
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer
Authoring Organizations
Publication Month/Year
January 18, 2022
Supplemental Implementation Tools
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Target Patient Population
Patients with early or locally advanced (nonmetastatic) breast cancer.
Target Provider Population
Medical oncologists and other clinicians involved in postsurgical (adjuvant) treatment of patients with breast cancer
Inclusion Criteria
Female, Adult, Older adult
Health Care Settings
Ambulatory, Outpatient
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Management
Keywords
breast cancer, bone modifying, bone-modifying agents, BMAs, Bisphosphonates, Breast Cancer
Source Citation
Eisen A, Somerfield MR, Accordino MK, et al. Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update. J Clin Oncol. 2021 Jan 18. doi:10.1200/JCO.21.02647